Supplements

Mommi provides solution to prenatal vitamin pill fatigue

Mommi provides solution to prenatal vitamin pill fatigue

By Mary Ellen Shoup

Pill fatigue is a growing battle throughout the supplements category as manufacturers experiment with different delivery formats. But the prenatal vitamin space targeting expectant mothers has been slow to innovate in this area, according to prenatal...

Use of aromatase inhibitor forms basis of warning letter

Use of aromatase inhibitor forms basis of warning letter

By Hank Schultz

A recently posted warning letter cites a New York company for the presence of an aromatase inhibitor in one of its dietary supplements. This class of chemicals is popular with strength trainers for its purported ability to suppress estrogen levels.

MEET THE WINNERS: Products of the Year

NutraIngredients Awards 2018: Highlights

MEET THE WINNERS: Products of the Year

By Staff Writer

With the NutraIngredients Awards over for another year, we take a deeper look at the winners of our Products of the Year category.

©iStock/MichaelJung

DISPATCHES FROM VITAFOODS EUROPE 2018

Timing nutrient intake for peak performance: Lessons for the industry

By Will Chu

The concept of nutrient timing still has a place among the supplements and recovery aids that make up the sports nutrition sector, as an expert believes manufacturers can harness its principles to enhance a product's effectiveness.

DSM CFO Geraldine Matchett said the company has built up an inventory of supplies to meet customer demand while its vitamin C facility in China is shut down for four months.

NEWS IN BRIEF

DSM benefits from temporary vitamin price effect while raising 2018 outlook

By Mary Ellen Shoup

DSM reported above market volume and sales gains for Q1 2018 with strong performance in its underlying nutrition business, which grew 5% in volume compared to the same period last year driven by strong sales in its i-Health and vitamin pre-mix businesses....

iStock / macgyverhh

P&G bags Merck consumer health unit for €3.4 bn

By Nathan Gray

Procter & Gamble will buy Merck KGaA’s consumer health unit for €3.4 billion euros – as the FMCG giant looks stem falling revenue by betting on vitamin ranges that have shown stable growth.

Follow us

Products

View more

Webinars